Yahoo Web Search

Search results

    • Junshi Biosciences Announces NDA Acceptance in Hong Kong for Toripalimab

      Morningstar· 7 hours ago

      ...: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug Office, Department...has recently accepted the New Drug Application (“NDA”) for toripalimab in combination with cisplatin and...